Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Postmenopausale Hormontherapie (HT)

Interpretation unterschiedlicher Daten bezüglich Nutzen und Risiko

  • 31 Accesses

This is a preview of subscription content, log in to check access.

Abb. 1

Literatur

  1. 1.

    Beckmann MW, Braendle W, Brucker C, Dören G, Emons G, Geisthövel F, Kiesel L, König K, Naß-Griegoleit I, Ortmann O (federführend), Rabe T, Windler E (2003) Konsensusempfehlung zur Hormontherapie (HT) im Klimakterium und in der Postmenopause. Geburtsh Frauenheilk 63: 209–212

  2. 2.

    Grady D, Herrington D, Bittner V et al., for the Heart and Estrogen Replacement Study (HERS) Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow up (HERS II). JAMA 288: 49–57

  3. 3.

    Grodstein F, Clarkson TB, Manson JA (2003) Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 348: 645–650

  4. 4.

    Grodstein F, Manson JE, Stampfer MJ (2001) Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study:a prospective, observational study. Ann Intern Med 135: 1–8

  5. 5.

    Humphrey LL, Chan BK, Sox HC (1997) Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 127: 501–508

  6. 6.

    Manson JE, Martin KA (2001) Postmenopausal hormone-replacement therapy. New Engl J Med 345: 34–40

  7. 7.

    Müller A, Cupisti S, Oppelt PG, Beckmann MW (2002) Hormonelle Therapiemöglichkeiten in der Menopause, Teil 2. GebFra-Refresher; Geburtsh Frauenheilkd 62: R1–R20

  8. 8.

    Mc Gill HC Jr, Stren MP (1979) Sex and atherosclerosis. Atheroscler Rev 4: 157–242

  9. 9.

    Nelson HD, Humphrey LL, Nygreen P, Teutsch SM, Allan JD (2002) Postmenopausal hormone replacement therapy—scientific review. JAMA 288: 872–881

  10. 10.

    Rodriguez C, Calle EE, Patel AV et al. (2001) Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. Am J Epidemiol 153: 145–152

  11. 11.

    Writing group for the Women's Health Initiative Investigators (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333

Download references

Author information

Correspondence to Prof. Dr. M. W. Beckmann.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Müller, A., Beckmann, M.W. Postmenopausale Hormontherapie (HT). Gynäkologe 36, 827–830 (2003). https://doi.org/10.1007/s00129-003-1407-5

Download citation